Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MCA.0000000000000408 http://scihub22266oqcxt.onion/10.1097/MCA.0000000000000408 C5042826!5042826!27414247     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Coron+Artery+Dis 2016 ; 27 (7): 592-603 Nephropedia Template TP {{tp|p=27414247|t=2016. The role of HDL on plaque stabilization and regression: basic mechanisms and clinical implications |pdf=|usr=}}{{27414247}} gab.com Text The role of HDL on plaque stabilization and regression: basic mechanisms and clinical implications JO: Coron Artery Dis http://www.kidney.de/pget.php?&tw=1&pmid=27414247 #FOAvip Based on studies that extend back to the early 1900s, regression and stabilization of atherosclerosis in humans has gone from a concept to one that is achievable. Successful attempts at regression generally applied robust measures to improve plasma lipoprotein profiles. Possible mechanisms responsible for lesion shrinkage include decreased retention of atherogenic apolipoprotein B within the arterial wall, efflux of cholesterol and other toxic lipids from plaques, emigration of lesional foam cells out of the arterial wall, and influx of healthy phagocytes that remove necrotic debris as well as other components of the plaque. Currently available clinical agents, though, still fail to stop most cardiovascular events. For years, HDL has been considered the ?good cholesterol.? Clinical intervention studies to causally link plasma HDL-C levels to decreased progression or to the regression of atherosclerotic plaques, are relatively few because of the lack of therapeutic agents to selectively and potently raise HDL-C. The negative results of studies that were performed have casted uncertainty as to the role HDL possesses in terms of atherosclerosis. It is becoming clearer, though, that HDL function rather than quantity is most crucial and therefore, discovering agents that enhance the quality of HDL should be the goal. Twit Text FOAVip The role of HDL on plaque stabilization and regression: basic mechanisms and clinical implications ????Coron Artery Dis http://www.kidney.de/pget.php?&tw=1&pmid=27414247 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27414247 #FOAvip English Wikipedia <ref>{{Cite pmid|27414247}}</ref> The role of HDL on plaque stabilization and regression: basic mechanisms and clinical implications #MMPMID27414247 Feig JE; Feig JL; Dangas GD Coron Artery Dis 2016[Nov]; 27 (7): 592-603 PMID27414247show ga Based on studies that extend back to the early 1900s, regression and stabilization of atherosclerosis in humans has gone from a concept to one that is achievable. Successful attempts at regression generally applied robust measures to improve plasma lipoprotein profiles. Possible mechanisms responsible for lesion shrinkage include decreased retention of atherogenic apolipoprotein B within the arterial wall, efflux of cholesterol and other toxic lipids from plaques, emigration of lesional foam cells out of the arterial wall, and influx of healthy phagocytes that remove necrotic debris as well as other components of the plaque. Currently available clinical agents, though, still fail to stop most cardiovascular events. For years, HDL has been considered the ?good cholesterol.? Clinical intervention studies to causally link plasma HDL-C levels to decreased progression or to the regression of atherosclerotic plaques, are relatively few because of the lack of therapeutic agents to selectively and potently raise HDL-C. The negative results of studies that were performed have casted uncertainty as to the role HDL possesses in terms of atherosclerosis. It is becoming clearer, though, that HDL function rather than quantity is most crucial and therefore, discovering agents that enhance the quality of HDL should be the goal. äThe role of HDL on plaque stabilization and regression: basic mechanis(epmc).pdf DeepDyve Pubget Overpricing